Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 10,000 shares at $29.78 ($298K) on 2014-08-14, disclosed to the SEC on 2014-08-15.
Scheduled sale ($298k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.77 | 7,400 | $220K | 74.0% |
| 2 | $29.78 | 2,500 | $74K | 25.0% |
| 3 | $30.37 | 100 | $3K | 1.0% |
| Total | $29.78 avg | 10,000 | $298K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |